Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul
What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the next generation of...
Search results for "patient"
Suspected Lung Cancer Turns Out to Be Parasite Eggs From Raw Freshwater Crab
A 60-year-old man visited a hospital after coughing up blood-tinged sputum for several months. Doctors discovered a small nodule in his lung and...
Fewer Radiation Sessions After Prostate Cancer Surgery Prove Equally Effective, Study Finds
Reducing the number of radiation therapy sessions intended to prevent prostate cancer recurrence by about 20 percent...
Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug
A domestically developed therapy has entered South Korea’s obesity treatment market, long dominated by imported...
Turned Away by Philippine Hospitals, 13-Year-Old Kopino Girl Finds Healing in Busan
For a year and a half, 13-year-old Torrado Maria Claudia lived with a visibly swollen left cheek.
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro
Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
Why Pancreatic Cancer Is So Hard to Catch Early—and Why Diet May Be Key
Imagine if a simple blood test could catch pancreatic cancer early. For now, that remains an ideal rather than reality.
Mongolian Archer Resumes Career After Elbow Surgery in South Korea
A Mongolian archer whose elbow injury threatened to end his career is preparing to return to competition following...
How High Blood Pressure Accelerates Joint Wear in Older Adults: A 'Brain Hormone' May Be to Blame
October 2 marks "Senior Citizens' Day" in South Korea—a statutory observance intended to foster respect for older...
Spatial Mapping of Residual Esophageal Cancer Reveals Genetic Clues to Recurrence Risk
Researchers have identified key genetic markers that could help estimate the risk of recurrence in esophageal cancer...